TradingView
JabezDolz
Apr 6, 2022 10:43 AM

NVCR ready to go on an extended run  Long

NovoCure LimitedNASDAQ

Description

Initial Target by Apr 14 = 99
Target Range by 5/20/2022 = 108-116

Upcoming earnings as a catalyst. Bullish Momentum for pre-earnings run up.

Kept the chart simple but a lot of bullish aspects at play here, to name a few:

- ready for markup coming off an accumulation phase
- completes wave 5 correction apprx. .786 off the highs last June
- if you look at the bigger structure it just completed a running flat beginning Aug 2019

Great Company!
Comments
Gamechangercap
guess we have to wait longer
ptybug
certainly hope so, been hurt since November by this stock :)
More